文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Anti-PD-1 therapy can possibly reverse CAR T cells exhaustion in DLBCL.

作者信息

Lamure Sylvain, Herbaux Charles

机构信息

Département d'Hématologie Clinique, CHU de Montpellier, Montpellier, France.

Hematopoiesis and Immunotherapy, Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Montpellier, France.

出版信息

Br J Haematol. 2023 Jul;202(2):217-218. doi: 10.1111/bjh.18797. Epub 2023 Apr 4.

DOI:10.1111/bjh.18797
PMID:37013670
Abstract
摘要

相似文献

[1]
Anti-PD-1 therapy can possibly reverse CAR T cells exhaustion in DLBCL.

Br J Haematol. 2023-7

[2]
Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti-CD19-chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B-cell lymphoma and high tumor burden.

Hematol Oncol. 2023-4

[3]
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.

Int J Mol Sci. 2018-12-19

[4]
Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma.

Int J Mol Sci. 2019-3-15

[5]
PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.

PLoS One. 2015-9-11

[6]
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.

Cancer Immunol Res. 2019-2-11

[7]
[Cellular kinetics and outcome of tisagenlecleucel for diffuse large B-cell lymphoma].

Rinsho Ketsueki. 2023

[8]
Prognostic value of PD-1 and TIM-3 on CD3+ T cells from diffuse large B-cell lymphoma.

Biomed Pharmacother. 2015-9-15

[9]
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.

Lancet Haematol. 2015-10

[10]
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.

Mol Cancer. 2019-3-30

引用本文的文献

[1]
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review.

Front Immunol. 2024

[2]
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012-2023).

Hum Vaccin Immunother. 2024-12-31

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索